Study
|
Variable
|
Hazard ratio
|
CI 95%
|
P value
|
---|
PLCO
|
Age
|
1.01
|
(1, 1.02)
|
0.08
|
Age and PSA interaction
|
0.89
|
(0.85, 0.94)
|
< 0.001*
|
BMI
|
1.01
|
(1, 1.02)
|
0.07
|
BPH
|
0.88
|
(0.81, 0.97)
|
0.01*
|
DRE
|
1.64
|
(1.46, 1.85)
|
< 0.001*
|
Family history of cancer
|
1.43
|
(1.27, 1.61)
|
< 0.001*
|
Finasteride use
|
0.69
|
(0.6, 0.79)
|
< 0.001*
|
Log (PSA)
|
5.52
|
(5.15, 5.93)
|
< 0.001*
|
African American
|
1.37
|
(1.15, 1.63)
|
< 0.001*
|
African American and BMI interaction
|
1.05
|
(0.89, 1.23)
|
0.58
|
SELECT
|
Age
|
1.01
|
(1, 1.02)
|
0.03*
|
Age and PSA interaction
|
0.83
|
(0.79, 0.88)
|
< 0.001*
|
BMI
|
1
|
(0.99, 1.01)
|
1
|
BPH
|
0.84
|
(0.75, 0.93)
|
0.001*
|
Family history of cancer
|
1.72
|
(1.58, 1.88)
|
< 0.001*
|
Finasteride use
|
0.98
|
(0.77, 1.25)
|
0.88
|
Log (PSA)
|
5.3
|
(4.92, 5.71)
|
< 0.001*
|
African American
|
1.29
|
(1.15, 1.44)
|
< 0.001*
|
African American and BMI interaction
|
1.15
|
(1.04, 1.27)
|
0.01*
|
- The bold and * denotes P-value < 0.05